Literature DB >> 7923231

The Delta Valve: a physiologic shunt system.

D A Watson1.   

Abstract

PS Medical has advanced the state-of-the-art in hydrocephalus valve technology with the introduction of the Delta Valve. The Delta Valve is designed upon the premise that the shunted patient should have intracranial pressure (ICP) maintenance within a normal range regardless of cerebrospinal fluid (CSF) flow rate or body position. All previous valves have performance characteristics that are greatly influenced by the negative hydrostatic pressure caused by the gravitational effect on the vertical water column in the distal catheter. This negative pressure influence is non-physiologic and contributes directly to overdrainage that can cause slit ventricles, subdural hematoma, and proximal catheter occlusions. The Delta Valve is the only valve that maintains a near-constant pressure gradient regardless of flow rate or patient posture. It automatically adjusts for increasing negative pressures in the distal catheter by proportionally increasing its resistance to flow, thus nullifying the adverse effects of the hydrostatic force on intracranial pressures. The result is a shunt system that provides for CSF drainage while allowing the patient's normal physiologic conditions to control ICP. The early use of the Delta Valve in the treatment of hydrocephalus may reduce the incidence of the dramatic complications associated with overdrainage.

Entities:  

Mesh:

Year:  1994        PMID: 7923231     DOI: 10.1007/bf00301158

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  21 in total

1.  Fluid flow performance of a new siphon-control device for ventricular shunts.

Authors:  D Horton; M Pollay
Journal:  J Neurosurg       Date:  1990-06       Impact factor: 5.115

2.  Experience with antisyphon devices: successes and complications.

Authors:  E Jaskolska; A E MacKinnon
Journal:  Z Kinderchir       Date:  1988-12

3.  Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas.

Authors:  H D Portnoy; R R Schulte; J L Fox; P D Croissant; L Tripp
Journal:  J Neurosurg       Date:  1973-06       Impact factor: 5.115

4.  Overdrainage phenomena in shunt treated hydrocephalus.

Authors:  K Faulhauer; P Schmitz
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

5.  Infantile hydrocephalus and the slit ventricle syndrome in early infancy.

Authors:  S Oi; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

6.  Experiences with the anti-siphon device (ASD) in shunt therapy of pediatric hydrocephalus.

Authors:  R Gruber; P Jenny; B Herzog
Journal:  J Neurosurg       Date:  1984-07       Impact factor: 5.115

7.  A new approach in the treatment of hydrocephalus.

Authors:  C Sainte-Rose; M D Hooven; J F Hirsch
Journal:  J Neurosurg       Date:  1987-02       Impact factor: 5.115

8.  The relationship of ventricular shunt complications to the chronic overdrainage syndrome: a follow-up study.

Authors:  R Gruber
Journal:  Z Kinderchir       Date:  1981-12

9.  Slit-ventricle syndrome: review of 15 cases.

Authors:  R L McLaurin; A Olivi
Journal:  Pediatr Neurosci       Date:  1987

10.  Symptomatic progressive ventriculomegaly in hydrocephalics with patent shunts and antisiphon devices.

Authors:  D C McCullough
Journal:  Neurosurgery       Date:  1986-10       Impact factor: 4.654

View more
  1 in total

1.  Ventriculo-peritoneal shunting devices for hydrocephalus.

Authors:  Luis Garegnani; Juan Va Franco; Agustín Ciapponi; Virginia Garrote; Valeria Vietto; Santiago Adalberto Portillo Medina
Journal:  Cochrane Database Syst Rev       Date:  2020-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.